Associate Research Scientist
[email protected]
Available to mentor
Stephanie S Tseng-Rogenski
Associate Research Scientist
-
Koi M, Leach BH, McGee S, Tseng-Rogenski SS, Burke CA, Carethers JM. NPJ Precis Oncol, 2024 Jan 19; 8 (1): 12Journal ArticleCompound heterozygous MSH3 germline variants and associated tumor somatic DNA mismatch repair dysfunction.
DOI:10.1038/s41698-024-00511-2 PMID: 38243056 -
Tseng-Rogenski SS, Munakata K, Choi DY, Martin PK, Mehta S, Koi M, Zheng W, Zhang Y, Carethers JM. Mol Cell Biol, 2020 Jun 15; 40 (13):Journal ArticleThe Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation.
DOI:10.1128/MCB.00029-20 PMID: 32284349 -
Munakata K, Koi M, Kitajima T, Tseng-Rogenski S, Uemura M, Matsuno H, Kawai K, Sekido Y, Mizushima T, Toiyama Y, Yamada T, Mano M, Mita E, Kusunoki M, Mori M, Carethers JM. Clin Transl Gastroenterol, 2019 Dec; 10 (12): e00105Journal ArticleInflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
DOI:10.14309/ctg.0000000000000105 PMID: 31789935 -
Koi M, Tseng-Rogenski SS, Carethers JM. World J Gastrointest Oncol, 2018 Jan 15; 10 (1): 1 - 14.Journal ArticleInflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer.
DOI:10.4251/wjgo.v10.i1.1 PMID: 29375743 -
Suzuki S, Iwaizumi M, Tseng-Rogenski S, Hamaya Y, Miyajima H, Kanaoka S, Sugimoto K, Carethers JM. Cancer Biol. Ther, 2016 Dec 7; 17 (7): 760 - 768.Journal ArticleProduction of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluoroucile sensitivity that is independent of hMLH1 status.
-
Suzuki S, Iwaizumi M, Tseng-Rogenski S, Hamaya Y, Miyajima H, Kanaoka S, Sugimoto K, Carethers JM. Cancer Biol Ther, 2016 Jul 2; 17 (7): 760 - 768.Journal ArticleProduction of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status.
DOI:10.1080/15384047.2016.1178430 PMID: 27115207 -
Hamaya Y, Guarinos C, Tseng-Rogenski SS, Iwaizumi M, Das R, Jover R, Castells A, Llor X, Andreu M, Carethers JM. PLoS One, 2015 10 (5): e0127591Journal ArticleEfficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
DOI:10.1371/journal.pone.0127591 PMID: 25996601 -
Carethers JM, Koi M, Tseng-Rogenski SS. Genes (Basel), 2015 Mar 31; 6 (2): 185 - 205.Journal ArticleEMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.
DOI:10.3390/genes6020185 PMID: 25836926
